46 /100
MEDIUM RISK
Score updated Jul 14, 2026

BHST — BioHarvest Sciences Inc. Common Stock Dilution Risk Tracker

Track BHST dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BHST — Get alerts when the score changes →

As of July 14, 2026, BioHarvest Sciences Inc. Common Stock (BHST) has a DilutionWatch DilutionScore of 46/100, rated MEDIUM dilution risk. BioHarvest Sciences Inc. Common Stock has a market capitalization of $87.50M, 22.67M shares outstanding, 20 institutional holders tracked.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
40
📊 Float Risk
22
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for BHST.
🔔 Track BHST — Get forecast alerts →

💹 Market Data

Market Cap$87.50M
Shares Outstanding22.67M
Float17.82M
Cash$23.02M
Debt$149.0K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 4.3% shares (2026Q1 vs prior)
20 institutional holders · 1.70M shares
#1 Alyeska Investment Group, L.P. 757.1K shares
#2 THOMPSON SIEGEL & WALMSLEY LLC 386.8K shares
#3 True North Advisors, LLC 168.0K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest72.0K
Days to Cover3.1
% of Float0.4%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for BHST Shareholders

BioHarvest Sciences Inc. Common Stock (BHST) has a DilutionScore of 46/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for BHST shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for BHST in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for BHST alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track BHST Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BHST — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for BHST
📊 BHST FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BHST Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.